Biotech Values

[DewDiligence]

JNJ/ARWR HBV presentations at AASLD:

https://www.businesswire.com/news/home/20191108005115/en

$ARWR HBV data out at #AASLD19 #LiverMtg19

1) Are they really calling this "dose response" from 100mg to 400mg with a straight face?https://t.co/kqB9nPETqP

2) Is JNJ-6379 CAM triple combo adding anything there?
-1.7log reduction looks same as duo combohttps://t.co/rxsF9kAsFX pic.twitter.com/1iKMZmv164

— Andy Biotech (@AndyBiotech) November 8, 2019

(note the second bullet point in partcular)